HYPR
Hyperfine, Inc. Healthcare Medical Devices
8/12
Innovation Score
Red Flags (1)
SBC_HIGH (56% of revenue)
Patent Activity
3/3
43 patents found
FUZZY
Cash Runway
1/3
15 months of cash remaining based on current burn rate.
Cash on hand: $35.1M
Cash on hand: $35.1M
Revenue Trajectory
3/3
Revenue: $13.6M
YoY Growth: +128.0%
YoY Growth: +128.0%
Management Quality
1/3
Insider ownership: 5.4%
SBC/Revenue: 56.2%
No reverse splits detected
SBC/Revenue: 56.2%
No reverse splits detected
Key Metrics
Market Cap
$166.5M
Revenue
$13.6M
Revenue Growth (YoY)
+128.0%
Cash on Hand
$35.1M
Cash Runway
15 months
Shares Outstanding
83.5M
Insider Ownership
5.4%
SBC / Revenue
56.2%
Sector / Industry
Healthcare / Medical Devices
Patents (43)
Match type: FUZZY — company name matched partially; verify assignee
- Self ensembling techniques for generating magnetic resonance images from spatial frequency data
- Systems and methods for performing magnetic resonance imaging with reduced operator interaction
- Artefact reduction in magnetic resonance imaging
- Methods and apparatus for patient positioning in magnetic resonance imaging
- Deep learning techniques for suppressing artefacts in magnetic resonance images
7-Step Risk Assessment
How HYPR maps to our micro cap methodology:
- Innovation Signal 43 patents identified. This suggests the company is investing in defensible IP.
- Cash Runway Check 15 months of runway. Short runway increases dilution risk — watch for capital raises.
- Revenue Trajectory +128.0% YoY growth on $13.6M revenue. Strong growth trajectory.
- Management Alignment Insiders hold 5.4% of shares. SBC is 56.2% of revenue.
- Competitive Moat Review the company's 10-K for barriers to entry: patents, network effects, switching costs, regulatory approvals. This step requires manual research.
- Catalyst Identification Look for upcoming catalysts: FDA decisions, contract wins, product launches, partnerships. Check recent 8-K filings and earnings transcripts.
- Position Sizing Micro caps carry outsized risk. Consider position sizing relative to conviction level and portfolio concentration. This is a $166.5M company.
Financial Detail
Free Cash Flow
$-17.2M
FCF Yield
-10.3%
Return on Equity
-79.0%
Debt / Equity
0.8%
Gross Margin
49.8%
Profit Margin
-262.3%
Operating Margin
-144.9%
Price / Book
4.00
Current Ratio
4.34
Dividend Yield
None
Share Count Change (YoY)
N/A
Share Count Change (3yr)
N/A
Quality Flags
Low Debt
Free Cash Flow Trend
Insufficient Data
Consecutive Years FCF Positive
0
Disclaimer: This is an automated screening tool, not investment advice. Micro cap stocks are inherently risky with low liquidity and high volatility. The innovation score is based on publicly available data and may not reflect the full picture. Steps 5-7 of the methodology require your own research. See our full disclaimer.
Last screened: 2026-05-11